Oivi’s mission is to provide affordable eye care for all. Our vision is to eliminate preventable blindness by providing a low-cost camera for retinal (fundus) photography, with fully automated image capture and Artificial Intelligence (AI) diagnostics. Our goal is for Oivi to become the point-of-care device for preventative eye screening, with diabetic retinopathy (DR) as our first area of focus. Oivi will have a disruptive effect in traditional DR value chain by changing the typical flow, location and cost of DR screening and diagnostics.
DR affects more than 160 million people worldwide and is the most common cause of blindness among people with diabetes. Within 10 years of onset, 75% of diabetics will have some degree of DR. However, early detection of DR in mild and moderate stages of the disease through eye examination, can reduce the risk of blindness by 95%.
Current solutions for DR screening and diagnostics are often expensive and require extensive training, which limits accessibility for patients, especially in developing countries, causing significant delays in detection and intervention, and consequently vision problems and/or high treatment costs. Oivi’s device is a unique combination of automated, easy-to-use, low-cost and diagnostic solutions in a small, highly portable design.
The overall objective is to improve understanding of our target market and customer segments, carry out technical feasibility studies, align business and technology strategy for commercialization and develop a co-creation approach to match the requirements of end-users and customers with Oivi’s final solution.
